tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Ligand Pharma Completes $460M Convertible Notes Offering
PremiumCompany AnnouncementsLigand Pharma Completes $460M Convertible Notes Offering
29d ago
Ligand Pharmaceuticals Inc. Reports Strong Q2 Earnings
Premium
Company Announcements
Ligand Pharmaceuticals Inc. Reports Strong Q2 Earnings
1M ago
Ligand Pharma Announces $400M Convertible Notes Offering
Premium
Company Announcements
Ligand Pharma Announces $400M Convertible Notes Offering
1M ago
Positive Outlook on Ligand Pharma: Strong Financial Performance and Strategic Positioning Drive Buy Rating
PremiumRatingsPositive Outlook on Ligand Pharma: Strong Financial Performance and Strategic Positioning Drive Buy Rating
1M ago
Ligand raises FY25 adjusted EPS view to $6.70-$7.00 from $6.00-$6.25
Premium
The Fly
Ligand raises FY25 adjusted EPS view to $6.70-$7.00 from $6.00-$6.25
1M ago
Ligand reports Q2 adjusted EPS $1.60, consensus $1.42
Premium
The Fly
Ligand reports Q2 adjusted EPS $1.60, consensus $1.42
1M ago
Ligand partner Pelthos launches ZELSUVMI topical gel
PremiumThe FlyLigand partner Pelthos launches ZELSUVMI topical gel
2M ago
Ligand Pharma Completes Merger Forming Pelthos Therapeutics
Premium
Company Announcements
Ligand Pharma Completes Merger Forming Pelthos Therapeutics
2M ago
Ligand announces completion of Pelthos Therapeutics merger with Channel
Premium
The Fly
Ligand announces completion of Pelthos Therapeutics merger with Channel
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100